IP-FCM Measures Physiologic Protein-Protein Interactions Modulated by Signal Transduction and Small-Molecule Drug Inhibition

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Smith, Stephen E P ^a   Bida, Anya T ^a,d   Davis, Tessa R ^a   Sicotte, Hugues ^b   Patterson, Steven E ^c   Gil, Diana ^a   Schrum, Adam G ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; AMPICILLIN; BIOTIN; CYCLOHEXIMIDE; FC RECEPTOR; GENTAMICIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; KANAMYCIN; LYMPHOCYTE ANTIGEN RECEPTOR; PHENYL PHOSPHATE; PHLEOMYCIN; PROTEIN INHIBITOR; PROTEIN KINASE ZAP 70; RO 26 4550; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

BLOTTING, WESTERN; FLOW CYTOMETRY; HUMANS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84866719263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045722     Document Type: Article

References (28)

1. Deverman BE, Patterson PH, (2009) Cytokines and CNS development. Neuron 64: 61-78.
2. Morris GP, Allen PM, (2012) How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol 13: 121-128.
3. Hirano T, (2006) At the heart of the chromosome: SMC proteins in action. Nat Rev Mol Cell Biol 7: 311-322.
4. Prasanth SG, Mendez J, Prasanth KV, Stillman B, (2004) Dynamics of pre-replication complex proteins during the cell division cycle. Philos Trans R Soc Lond B Biol Sci 359: 7-16.
5. Richardson KS, Zundel W, (2005) The emerging role of the COP9 signalosome in cancer. Mol Cancer Res 3: 645-653.
6. Kay BK, Paul JI, (1996) High-throughput screening strategies to identify inhibitors of protein-protein interactions. Mol Divers 1: 139-140.
7. Arkin MR, Wells JA, (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 3: 301-317.
8. Blazer LL, Neubig RR, (2009) Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. Neuropsychopharmacology 34: 126-141.
9. Laudet B, Moucadel V, Prudent R, Filhol O, Wong YS, et al. (2008) Identification of chemical inhibitors of protein-kinase CK2 subunit interaction. Mol Cell Biochem 316: 63-69.
10. Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, et al. (2006) A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res 66: 1767-1774.
11. Colas P, (2008) High-throughput screening assays to discover small-molecule inhibitors of protein interactions. Curr Drug Discov Technol 5: 190-199.
12. Bida AT, Gil D, Schrum AG, (2011) Multiplex IP-FCM (immunoprecipitation-flow cytometry): Principles and guidelines for assessing physiologic protein-protein interactions in multiprotein complexes. Methods 56: 154-160.
13. Davis TR, Schrum AG (2010) IP-FCM: immunoprecipitation detected by flow cytometry. J Vis Exp.
14. Schrum AG (2009) Visualization of multiprotein complexes by flow cytometry. Curr Protoc Immunol Chapter 5: Unit5 9.
15. Schrum AG, Gil D, Dopfer EP, Wiest DL, Turka LA, et al. (2007) High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry. Sci STKE 2007: pl2.
16. Schrum AG, Gil D, Turka LA, Palmer E, (2011) Physical and functional bivalency observed among TCR/CD3 complexes isolated from primary T cells. J Immunol 187: 870-878.
17. Wilson CG, Arkin MR, (2010) Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied. Curr Top Microbiol Immunol 348: 25-59.
18. Dietz AB, Bulur PA, Emery RL, Winters JL, Epps DE, et al. (2006) A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46: 2083-2089.
19. de la Cruz J, Kruger T, Parks CA, Silge RL, van Oers NS, et al. (2011) Basal and antigen-induced exposure of the proline-rich sequence in CD3epsilon. J Immunol 186: 2282-2290.
20. Gil D, Schrum AG, Alarcon B, Palmer E, (2005) T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes. J Exp Med 201: 517-522.
21. Gil D, Schrum AG, Daniels MA, Palmer E, (2008) A role for CD8 in the developmental tuning of antigen recognition and CD3 conformational change. J Immunol 180: 3900-3909.
22. Schrum AG, Turka LA, Palmer E, (2003) Surface T-cell antigen receptor expression and availability for long-term antigenic signaling. Immunol Rev 196: 7-24.
23. Smith-Garvin JE, Koretzky GA, Jordan MS, (2009) T cell activation. Annu Rev Immunol 27: 591-619.
24. Stefanova I, Dorfman JR, Germain RN, (2002) Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420: 429-434.
25. Tilley JW, Chen L, Fry DC, Emerson SD, Powers GD, et al. (1997) Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2. Journal of the American Chemical Society 119: 7589-7590.
26. Raimundo BC, Oslob JD, Braisted AC, Hyde J, McDowell RS, et al. (2004) Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: Äâ An Approach for Inhibiting Protein, àíProtein Interactions'Ć. Journal of Medicinal Chemistry 47: 3111-3130.
27. Berggard T, Linse S, James P, (2007) Methods for the detection and analysis of protein-protein interactions. Proteomics 7: 2833-2842.
28. Mullard A, (2012) Protein-protein interaction inhibitors get into the groove. Nat Rev Drug Discov 11: 173-175.